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Original Article
The effect of hyperglycemia
on neurovascular coupling and
cerebrovascular patterning in zebrafish
Karishma Chhabria1,2,3 , Karen Plant2,3, Oliver Bandmann3,4,
Robert N Wilkinson2,3, Chris Martin1,5, Elisabeth Kugler2,3 ,
Paul A Armitage1,2, Paola LM Santoscoy3,6,
Vincent T Cunliffe3,6, Jan Huisken7, Alexander McGown3,4,
Tennore Ramesh3,4, Tim JA Chico1,2,3 and Clare Howarth1,5
Abstract
Neurovascular coupling (through which local cerebral blood flow changes in response to neural activation are mediated)
is impaired in many diseases including diabetes. Current preclinical rodent models of neurovascular coupling rely on
invasive surgery and instrumentation, but transgenic zebrafish coupled with advances in imaging techniques allow non-
invasive quantification of cerebrovascular anatomy, neural activation, and cerebral vessel haemodynamics. We therefore
established a novel non-invasive, non-anaesthetised zebrafish larval model of neurovascular coupling, in which visual
stimulus evokes neuronal activation in the optic tectum that is associated with a specific increase in red blood cell speed
in tectal blood vessels. We applied this model to the examination of the effect of glucose exposure on cerebrovascular
patterning and neurovascular coupling. We found that chronic exposure of zebrafish to glucose impaired tectal blood
vessel patterning and neurovascular coupling. The nitric oxide donor sodium nitroprusside rescued all these adverse
effects of glucose exposure on cerebrovascular patterning and function. Our results establish the first non-mammalian
model of neurovascular coupling, offering the potential to perform more rapid genetic modifications and high-throughput
screening than is currently possible using rodents. Furthermore, using this zebrafish model, we reveal a potential strategy
to ameliorate the effects of hyperglycemia on cerebrovascular function.
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Introduction
Neurovascular coupling refers to the mechanism by
which neural activation evokes a local increase in cere-
bral blood ﬂow.1,2 Impaired neurovascular coupling is
proposed to underlie a range of disorders including
neurodegeneration and dementia3–5 and is impaired in
animal models of diabetes.4,6 Preclinical studies of neu-
rovascular coupling currently rely on mammalian
models, which are highly invasive, requiring surgical
exposure and instrumentation of the brain. A less inva-
sive model would therefore be desirable. The zebraﬁsh
is an established model for studying the development
of the brain7,8 and vasculature9 and is increasingly
used to model human disease.10 Advanced imaging,
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particularly single plane illumination microscopy
(SPIM)11 provides rapid imaging allowing non-invasive
observation of dynamic phenomena such as neuronal
activation or blood ﬂow in living animals. Drugs can be
administered by immersion, allowing rapid testing of
potentially therapeutic compounds.12 These advantages
allow novel approaches to understanding mechanisms
of disease and identifying potential therapeutics.
We here describe non-invasive quantiﬁcation of neu-
rovascular anatomy, haemodynamics and neural acti-
vation simultaneously in non-anaesthetised zebraﬁsh.
We show that, like mammals, zebraﬁsh larvae after a
certain stage of development exhibit neurovascular cou-
pling. Chronic exposure of larvae to glucose impairs
both cerebrovascular patterning and neurovascular
coupling, and reduced expression of a reporter
expressed in the blood–brain barrier. Lastly, sodium
nitroprusside (SNP), a drug widely used clinically for
hypertension13 was able to reverse all the adverse eﬀects
of hyperglycaemia on cerebrovascular development and
neurovascular coupling, uncovering a possible thera-
peutic strategy to protect the brain from the eﬀects of
diabetes.
Methods
Transgenic zebrafish
Zebraﬁsh studies were in accordance with the Animals
(Scientiﬁc Procedures) Act, 1986, United Kingdom and
were performed under Home Oﬃce Project licence 70/
8588 held by TC. All procedures were approved by the
Ethical Review Committee at the University of
Sheﬃeld. Reporting of these experiments complies
with the ARRIVE (Animal Research: Reporting in
Vivo Experiments) guidelines. Zebraﬁsh expressed
three transgenes: kdrl:mCherry,14 gata1:DsRed15 and
nbt:GCaMP3 expressing the genetically encoded cal-
cium reporter GCaMP3 under control of the neuronal
beta-tubulin (NBT) promoter.16 For the claudin5a:GFP
reporter expression studies, zebraﬁsh expressed the
transgenes claudin5a:GFP17 and kdrl:mCherry.14
Adult ﬁsh were maintained on a 14/10-h light/dark
cycle and tanks of transgenic carriers incrossed to gen-
erate embryos for the studies described. These were
raised according to standard protocols.18
Lightsheet microscopy
Non-anaesthetised zebraﬁsh at the indicated age were
mounted individually in 3% low melting point (LMP)
agarose (Sigma) within a 1mm diameter glass capillary
bathed in E3 medium (5mM NaCl, 0.17mM KCl,
0.33mM CaCl2, 0.33mM MgSO4) within the chamber
of a Zeiss Z1 lightsheet microscope maintained at
28 C. The region of interest (ROI) was excited with a
lightsheet generated by 488 nm (50mW) and 561 nm
(50mW) lasers sequentially; 488 nm laser power was
30–50% and 561 nm laser power 1–2%. Emitted light
was collected using an LP560 ﬁlter.
To visualise cerebrovascular anatomy in the optic
tectum, a 90–100 mm Z stack was obtained with 1 mm
slices.
To visualise neurovascular coupling, the animal was
left for 3–4min in the dark to acclimatise before a single
sagittal Z slice was imaged serially at 32 frames/s at the
level of the superior granular layer of the optic tectum
(stratum opticum). After 29 s baseline imaging, a 5V
red (700 nm) light emitting diode (LED) inside the
chamber was used to administer a visual stimulus last-
ing 8 s. After the stimulus ended, imaging continued for
a further 29 s. The total time series (66 s) dataset there-
fore comprised 2100 frames. This was performed twice
per animal.
Glucose, mannitol, and SNP exposure
Glucose, mannitol, and SNP (Sigma) were dissolved in
E3 medium to ﬁnal concentrations of 20mM (360mg/
dL) (glucose and mannitol) or 0.1mM (SNP).
Embryos were incubated in E3 medium containing
these drugs at the ages and durations indicated.
Medium was replaced every day, and embryos imaged
as above at the time points indicated.
Image analysis: Quantification of red blood cell speed
Time series datasets from all visible x-y plane vessels in
the left optic tectum chosen were post processed in
MATLAB. Using our custom codes (available on
request), red blood cells (RBC) were segmented (by
intensity based thresholding followed by pre-processing
ﬁlters) in each frame followed by tracking of their cen-
troids using an object-tracking algorithm.
RBC speed in mm/s was derived using the equation
RBCspeed m=sð Þ ¼ fps scale
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Disp2x þDisp
2
y
q
ð1Þ
where fps represents image acquisition rate (fps), scale
is pixel to mm conversion (1 pixel¼ 0.609 mm 0.609
mm with image dimension 487 mm 365 mm), Dispx
and Dispy are pixel displacements in ‘x’ and ‘y’ direc-
tion, respectively.
The speed obtained (from equation (1)) is then pro-
cessed using modiﬁed interpolation and moving aver-
age ﬁlters (bin size of 3 s). Baseline, response and
recovery speed are then compared in GraphPad
Prism. For comparison between diﬀerent groups,
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increase in speed is calculated as diﬀerence between
average speed during response period (tresp) and
during baseline period (tbase) given by equation (2)
RBCspeed ¼
1
tresp
X
tresp
RBCspeed 
1
tbase
X
tbase
RBCspeed
ð2Þ
Image analysis: Neuronal activation
Neuronal activation in the left optic tectum was quanti-
ﬁed by GCaMP3 intensity (average over the entire left
optic tectum) using Zen Black software (Zeiss). Relative
change in ﬂuorescence was calculated by equation (3)
F
Fo
¼
F Bð Þ  Fo  Boð Þ
Fo  Bo
ð3Þ
where F is GCaMP3 intensity within an ROI which
covers the whole left optic tectum, B is intensity of
background area, Fo and Bo are baseline ﬂuorescence
(average of 10 s before stimulus onset) for optic tectum
and background given by a general equation
X ¼
1
T
X
t
X ð4Þ
where X ! F for optic tectum and X!B for back-
ground area, t represents the integration time period
averaged over total length, T, of the baseline. Time to
peak and time to half peak were quantiﬁed for peaks
induced by stimulus onset and stimulus oﬀset.
Image analysis: Vascular segmentation and
quantification
Vascular features (branch points, vessel length, radius
of vessels) were quantiﬁed using the Z stacks acquired
as above. These were pre-processed and segmented
using a processing pipeline similar to RBC segmenta-
tion. However, we used Otsu’s thresholding19 instead of
intensity-based thresholding to account for variable
vessel ﬂuorescence.
Morphological thinning20 was applied to obtain vas-
cular centerlines (2D maximum intensity projections of
the 3D stack), followed by branch points, vessel lengths,
and radius quantiﬁcation. For radius measurements,
edge information was obtained from the binary seg-
mented vasculature.20 Radius, R, was then calculated as
Euclidean distance between the centerlines, C, and vas-
culature edges, E, for all the vessels using the following
R ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
C Eð Þ2
q
ð5Þ
To obtain distribution of radii, 2D radii for each
vessel were used to calculate the frequency of each
unique radius value in the left optic tectum.
Image analysis: Quantification of claudin 5a intensity
Tg(claudin5a:GFP;kdrl:mCherry) was used to assess
the BBB integrity, quantiﬁed using Z stacks acquired
as above. Claudin 5a intensity was quantiﬁed as the
average green channel intensity in masked out left
optic tectum vessels (segmented using the vascular seg-
mentation method described above). This was normal-
ized to the vascular density in the left optic tectum for
each animal in each group: mannitol or glucose; with or
without SNP. This normalization was performed to
reduce any bias due to treatment-induced diﬀerences
in the vascular length.
Experimental design and statistical analysis
Experiments were designed using the experimental
design assistant of the NC3Rs online NC3RS-EDA
tool.21 GraphPad Prism (La Jolla, CA) was used for
statistical comparisons. Before performing statistical
analysis, data were tested for normality using the
Shapiro–Wilk test. Neuronal calcium peaks and RBC
speed in diﬀerent time periods were compared using
either a parametric one-way repeated measure
ANOVA (RM-ANOVA, for normally distributed
data) or a Friedman test (otherwise). Intergroup com-
parisons of neuronal activations and RBC speed for
each time period (baseline, response and recovery) for
various treatments (drugs/mannitol/glucose) were per-
formed using parametric two-way ANOVA. For all
ANOVA tests, intergroup comparisons were done
using Sidak’s multiple comparisons (post hoc) tests to
obtain statistical diﬀerence between individual pairs of
groups. Paired T-tests were used for two-group com-
parisons between tectal and non-tectal blood vessel
RBC increases in response to light stimulation.
Comparisons of vascular features such as number of
tectal branch-points, vascular length and radii between
two groups used unpaired t-tests or for more than two
groups used parametric one-way ANOVA. P
values< 0.05 were considered to be statistically signiﬁ-
cant. Data are mean standard deviation (s.d.), unless
otherwise speciﬁed. Box plots represent the median
with box edges representing 25% and 75% of the
data and end lines indicating the maximum and min-
imum data values. Imaging was performed unblinded
to treatment allocation; data analysis was automated
and thus not subject to operator bias. Randomization
of larvae to treatment group was not performed.
All data and codes used for the analysis are available
on request.
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Results
Zebrafish larvae develop neurovascular coupling
between 6 and 8 dpf
We ﬁrst examined whether zebraﬁsh exhibit neurovas-
cular coupling. We mounted non-anaesthetised eight
days post fertilisation (dpf) transgenic zebraﬁsh larvae
in the chamber of a lightsheet microscope. Larvae
expressed three transgenes: Tg(kdrl:Has.HRAS-
mCherry)14 labelling endothelial cell membranes,
Tg(gata1:DsRed)15 labelling erythrocytes allowing
quantiﬁcation of erythrocyte/RBC speed, and
Tg(nbt:GCaMP3)16 which reports neuronal cytoplas-
mic calcium levels. An increase in GCamP3 ﬂuores-
cence is indicative of an increase of neuronal electrical
activity.16,22 Combining these allowed simultaneous
quantiﬁcation of neuronal activation, cerebrovascular
anatomy, and RBC speed in individual cerebral vessels.
After baseline imaging of the optic tectum, we exposed
the animal to a pulse of red light for 8 s and continued
imaging during and after this visual stimulus, with each
stimulus protocol repeated twice per animal.
Figure 1(a) shows representative images of the left
optic tectum during these experiments. Neuronal
GCamp3 (shown in green) increased in ﬂuorescent
intensity during the visual stimulus before returning
to baseline 14 s after stimulus. This increase in ﬂuores-
cence represents an increase in neuronal calcium levels,
indicating increased neuronal activity. When we quan-
tiﬁed this neuronal response (expressed as F/Fo) in
ﬁve 8 dpf larvae (Figure 1(c)), we observed peaks in
neuronal calcium levels. These peaks were observed at
various times during the visual stimulus but most reli-
ably seen in association with onset (9% of all animals)
and oﬀset (78% of all animals) of the visual stimulus.
Representative examples of such responses are shown
in Supplemental Figure 1(a) to (c).
We thus divided the duration of the experiment into
three time periods relative to onset of visual stimulus:
baseline (10 to 0 s), response (0–20 s) and recovery
(20–30 s).
We next examined RBC speed in the blood vessels of
the left optic tectum to determine whether neuronal
activation was associated with alteration in cerebral
haemodynamics. Figure 1(b) shows the displacement
of individual RBCs in the same animal as shown in
Figure 1(a) at each timepoint, showing that this
increased during stimulus. We quantiﬁed this response
and found that RBC speed in the tectal vessels
increased during the response, compared with baseline
and recovery time periods (Figure 1(d)).
We quantiﬁed the neuronal and haemodynamic
responses to visual stimulus in larger groups of animals.
Frequency of Ca2þ peaks indicative of neuronal activa-
tion was signiﬁcantly higher during the response
compared with baseline and recovery periods, conﬁrm-
ing that visual stimulus induced neural activation in the
optic tectum (Figure 1(e)). We quantiﬁed the peak
onset times (time to half peak amplitude (t1/2)
23) for
peaks induced by onset and oﬀset of light stimulus;
these were: onset 431 254ms and oﬀset 366 101ms
(mean s.d.), similar to values reported for GCaMP3
activation in previous studies.23
We next measured RBC speed in the tectal vessels to
determine whether this altered in response to neuronal
activation as evidence of neurovascular coupling. Mean
RBC speed in the tectal blood vessels was signiﬁcantly
increased during the response compared with baseline
and recovery periods (Figure 1(f)). We examined the
temporal relationships between onset of visual stimu-
lus, neuronal activation and change in RBC speed in
each animal and found that the mean time between
stimulus onset and peak neuronal activation was
6.9 2.0 s (mean s.d.), and the mean time between
stimulus onset and peak RBC speed was 13.3 3.1 s
(mean s.d.), (Supplemental Figure 1). To examine
whether such an increase was due to a systemic eﬀect,
rather than localised to the area of neuronal activation,
we measured RBC speed in both non-tectal cere-
bral blood vessels (in the hindbrain and forebrain)
and the dorsal aorta in response to the same visual
stimulus. As expected, baseline RBC speed was not
diﬀerent between tectal and non-tectal cerebral vessels,
but was signiﬁcantly higher in the dorsal aorta
(Figure 1(g)). However, visual stimulus only increased
RBC speed in the tectal vessels, not the non-tectal
vessels or dorsal aorta (Figure 1(h)). To further
exclude a systemic eﬀect of the visual stimulus, we rec-
orded the heart rate during baseline, response and
recovery periods and found that this did not diﬀer
(Figure 1(i)).
To examine whether exposure to the 488 nm laser
used to image the neuronal calcium reporter contribu-
ted to the alteration in RBC speed in the tectal vessels,
we repeated experiments using an 8 s 488 nm laser illu-
mination in place of visible red light while constantly
recording RBC speed in the tectal vessels (via constant
excitation with a 561 nm laser). Unlike the response to
visible red light seen in Figure 1(e) and (f), the 488 nm
laser excitation had no signiﬁcant eﬀect on RBC speed
(Supplemental Figure 2).
To examine the eﬀect of diﬀerent stimulus protocols,
we repeated these experiments using a 4 s and 12 s
stimulus with red light (Supplemental Figure 3). We
found that there was no signiﬁcant diﬀerence in the
change in neuronal peak frequency between baseline
and stimulus periods with 4 s, 8 s, or 12 s visual stimu-
lus, although there was a non-signiﬁcant trend to a
longer time to half peak in response to 4 s compared
with 8 s and 12 s stimulus. However, the change in RBC
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Figure 1. 8 dpf zebrafish larvae display neurovascular coupling. (a) The left optic tectum of an 8 dpf Tg(nbt:GCaMP3;
kdrl:mCherry;gata1:DsRED) embryo before (10 s), during (2 s and 8.3 s) and after (14 s) visual stimulus by red light. Arrow indicates
area of increased tectal calcium levels in response to the stimulus. (b) Segmented RBCs shown for two consecutive frames (Framen
and Framenþ1) for corresponding time point of the neuronal responses shown in (a). Individual RBCs are labelled in green to represent
Framen and magenta to represent Framenþ1. (c) Quantification of neuronal activation (F/Fo) in optic tectum over time (n¼ 5 larvae).
Visual stimulus was administered 0–8 s (indicated on graph). Timeseries was divided into baseline (10 – 0 s), response (0–20 s), and
recovery (20–30 s) periods. (d) Erythrocyte (RBC) speed in tectal vessels in the same animals as (c). (e) Quantification of frequency of
peaks in (F/Fo) as a measure of neuronal activation during baseline, response and recovery time periods (n¼ 40 larvae). (f) Mean RBC
speed in the tectal vessels during baseline, response and recovery time periods in the same animals as (e). (g) Baseline RBC speed in
tectal vessels, non-tectal (hindbrain and forebrain) vessels and dorsal aorta. (h) RBC speed expressed as percentage from the baseline
for baseline, response and recovery for tectal vessels, non-tectal vessels and dorsal aorta (n¼ 17 larvae/group). (i) Beating heart rate
(bpm) quantified for baseline, response and recovery time periods (n¼ 9 larvae/group). *p< 0.05, **p< 0.01, ****p< 0.0001. Scale bar
represents 20mm. Data in (e) and (f) are median and interquartile range (25% and 75% percentile). All other data are mean s.d.
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speed in response to stimulus did not signiﬁcantly diﬀer
between any of these stimulus durations.
We next examined the eﬀect of four pulses of 4 s light
(with 4 s intervals) to see whether this induced a more
pronounced neurovascular response, but found that
although this led to an increase in RBC speed earlier
in the stimulus period, the neuronal and RBC speed
responses were very similar to an 8 s stimulus
(Supplemental Figure 4). We therefore used 8 s stimuli
for all further studies here reported.
Since all animals underwent two stimulus trials, we
examined the reproducibility and variability between
these trials in each animal. We found no signiﬁcant
diﬀerence between either change in neuronal peak fre-
quency or change in RBC speed between the ﬁrst and
second trial (Supplemental Figure 5).
Based on the data shown in Figure 1 and
Supplemental Figures 1 to 5, we conclude that 8 dpf
zebraﬁsh embryos exhibit neurovascular coupling in the
optic tectum in response to visual stimulus.
Rats develop classical neurovascular coupling
around p23.24 We therefore examined whether a similar
developmental threshold of neurovascular coupling
exists in zebraﬁsh. Visual stimulus had no eﬀect on
neuronal activation (frequency of calcium peaks) in 4
dpf embryos (Figure 2(a)) preventing assessment of
whether neurovascular coupling exists at this age. In
comparison, 6 dpf larvae exposed to visual stimulus
did show a signiﬁcant increase in neuronal activation
in the optic tectum (Figure 2(a)), of a similar magnitude
to that seen in 8 dpf larvae in Figure 1(e). However, the
increase in neural activation induced by visual stimulus
in 6 dpf larvae was not accompanied by an increase in
RBC speed (Figure 2(b)) as seen in 8 dpf larvae. This
divergent haemodynamic response between diﬀerent
developmental stages was not due to diﬀerent baseline
tectal vessel RBC speed (Figure 2(c)). Therefore, 8 dpf,
but not 6 dpf zebraﬁsh larvae exhibited an increase in
RBC speed (RBC speed) in response to visual stimu-
lus-evoked neural activation (Figure 2(d)). Thus, our
data demonstrate that, similarly to mammals, zebraﬁsh
exhibit a developmental threshold for neurovascular
coupling, which occurs between 6 and 8 dpf.
The effect of glucose exposure on zebrafish
cerebrovascular anatomy and neurovascular coupling
We next examined the eﬀect of hyperglycemia induced
by incubation in glucose on cerebrovascular anatomy
and function in zebraﬁsh. Larvae were incubated in
20mM glucose (a level seen in poorly controlled dia-
betes) or 20mM mannitol (osmotic control) at 4 dpf for
12, 60, 96 and 120 h to examine the eﬀect of glucose on
cerebrovascular patterning (Figure 3) and neural acti-
vation and tectal vessel RBC speed in response to visual
stimulus (Figure 4).
Figure 3(a) shows representative micrographs of the
cerebral vessels of larvae exposed to glucose or manni-
tol. Glucose exposure for 12 h (from 4 to 4.5 dpf) or
60 h (from 4 to 6.5 dpf) had no signiﬁcant eﬀect on
tectal vessel anatomy. However, 96 h (from 4 to 8
dpf) glucose exposure signiﬁcantly impaired cerebro-
vascular patterning judged by branchpoint number
(Figure 3(b)), and total tectal vessel length
(Figure 3(c)) though mean tectal vessel radius was not
signiﬁcantly diﬀerent (Figure 3(d) and (e)). By 120 h
Figure 2. Neurovascular coupling in zebrafish develops after 6 dpf. (a) Quantification of frequency of peaks in (F/Fo) as a measure
of neuronal activation during the baseline, response and recovery time periods for 4dpf and 6dpf (n¼ 17 larvae/group). (b) Mean RBC
speed during baseline, response and recovery time periods in the same animals as (a) (n¼ 17 larvae/group). (c) Mean baseline RBC
speed in tectal vessels in 4, 6 and 8 dpf zebrafish. (d) Change in RBC speed (RBC) in response to stimulus in 4, 6, and 8 dpf (n¼ 17
larvae/group). *p< 0.05, **p< 0.01. Data in (a) and (b) are mean s.d.
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Figure 3. Effect of glucose exposure on cerebrovascular patterning in zebrafish. (a) Representative micrographs of cerebral vessels
exposed to 20mM mannitol or glucose from 4 dpf for 12 h, 60 h, 96 h and 120 h. Square indicates region of left optic tectum quantified
in (b)–(e). (b) Number of tectal vessel branchpoints (n¼ 17, 16, 15 and 20 larvae for 12 h, 60 h, 96 h and 120 h exposure, respectively).
(c) Total tectal vessel length in same animals as (b). (d) Mean tectal vessel radius in same animals as in (b). (e) Histograms of tectal
vessel radii of tectal vessels in same animals as in (b). Scale bar represents 20 mm. Data are mean s.d.
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(from 4 to 9 dpf) exposure, all these measures of vas-
cular patterning were signiﬁcantly impaired by glucose
(Figure 3(b) to (e)).
When we examined the eﬀect of glucose on the
neural response to visual stimulus, we found no signiﬁ-
cant diﬀerence between glucose and mannitol exposed
larvae up to 120 h exposure (4 to 9 dpf, Figure 4(a) and
(b)). Baseline RBC speed (prior to visual stimulus) was
not signiﬁcantly diﬀerent at 4.5 dpf, 6.5 dpf or 8 dpf in
the glucose exposed group, but was signiﬁcantly
reduced at 9 dpf (120 h of glucose exposure)
(Figure 4(c)).
Figure 4. Effect of glucose exposure on neurovascular function in zebrafish. (a) Time series of neuronal activation (F/Fo) and tectal
vessel RBC speed in zebrafish exposed to 20mM mannitol or glucose from 4 dpf for 12 h, 60 h, 96 h and 120 h (n¼ 5 larvae/group).
(b) Change in neuronal calcium peak frequency in the left optic tectum during response compared to baseline periods (n¼ 17, 17, 15
and 20 for 12 h, 60 h, 96 h and 120 h exposure, respectively). (c) Baseline RBC speed at the same time points in (b) and (c). (d) Change
in RBC speed (RBC) between baseline and response time periods for the same animals as (b). ***p< 0.005, ****p< 0.0001. Data are
mean s.d.
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Consistent with the observation that neurovascular
coupling does not develop in zebraﬁsh until after 6 dpf,
RBC speed in response to neuronal activation was
low and not signiﬁcantly diﬀerent between glucose
and mannitol-treated animals at 4.5 and 6.5 dpf (12 h
and 60 h treatment) (Figure 4(d)). However, although 8
dpf larvae treated to mannitol displayed a signiﬁcant
increase in tectal vessel RBC speed in response to
neural stimulus, glucose-treated embryos did not. By
9 dpf (120 h after commencing treatment), RBC
speed in the optic tectum in response to visual stimulus
was signiﬁcantly reduced by glucose compared with
mannitol (Figure 4(d)). This result cannot be explained
by an absence of glucose in the mannitol-treated group
as repeating these experiments found no diﬀerence
between animals treated for ﬁve days from 4 dpf with
20mM mannitol compared with animals treated with
15mM mannitol plus 5mM glucose (Supplemental
Figure 6).
Collectively, our data show that chronic exposure to
20mM glucose (but not 5mM) impairs cerebrovascular
anatomy, baseline tectal vessel RBC speed, and neuro-
vascular coupling in zebraﬁsh.
The NO donor SNP rescues the adverse effects of
glucose on cerebrovascular anatomy and neurovas-
cular coupling in zebrafish
Multiple reports show that nitric oxide (NO) generation
is impaired in diabetes.25–27 Since both vascular devel-
opment and neurovascular coupling are NO-depen-
dent, we examined whether the NO donor SNP could
ameliorate the negative eﬀects of exposure to glucose.
We therefore exposed 4 dpf embryos to 20mM glucose
or mannitol for 120 h until 9 dpf (as in Figures 3 and 4)
and examined the eﬀect of co-treatment with or without
0.1mM SNP for 24 h starting at 8 dpf (96 h after start-
ing glucose or mannitol exposure. Figure 5(a) summar-
ises the timings and durations of drug treatment in
these four groups). Five days exposure to mannitol
plus 24 h treatment with SNP had no eﬀect on tectal
branchpoint number, total vascular length, or mean
vessel radii compared with mannitol alone (Figure
5(b) to (f)). As we previously found, 20mM glucose
from 4 to 9 dpf reduced tectal vessel branching,
length, and mean radius (Figure 5(b) to (f)).
However, 24 h SNP co-treatment (started at 8 dpf)
completely reversed the eﬀects of glucose on cerebro-
vascular anatomy (Figure 5(b) to (f)).
We next examined the eﬀect of 24 h SNP co-treat-
ment on neurovascular coupling in the same animals as
shown in Figure 5. SNP co-treatment with mannitol did
not aﬀect neurovascular coupling compared with man-
nitol alone (Figure 6). As we observed earlier, glucose
exposure from 4 to 9 dpf signiﬁcantly impaired both
baseline tectal vessel RBC speed and the visual stimu-
lus-evoked increase in RBC speed, while having no
eﬀect on the neuronal calcium response to a visual
stimulus; 24 h co-treatment with SNP prevented this
impairment in both baseline RBC speed and visual sti-
mulus-induced increase in RBC speed (RBC speed,
Figure 6(f)). These diﬀerences were not due to any dif-
ference in heart rate as this did not diﬀer between base-
line, response or recovery periods, or between
treatment groups (Figure 6(g)). Thus, 24 h treatment
with SNP both prevented the cerebrovascular pattern-
ing defects associated with 120 h glucose exposure, and
furthermore prevented glucose-induced impairment of
neurovascular coupling.
We next sought to examine whether the eﬀects of
glucose in our model might be mediated via alteration
of the blood–brain barrier (BBB). Claudin 5 is a key
component of the BBB,28 and a transgenic zebraﬁsh has
recently been generated that expresses GFP driven by
the claudin5a promoter.17 We therefore examined the
eﬀect of ﬁve days mannitol or glucose exposure from 4
dpf, with or without SNP for one day from 8 dpf (as
shown in Figure 5(a)), on expression of the
claudin5a:GFP reporter in the tectal blood vessels.
Figure 7(a) shows representative micrographs from
these animals, revealing clear expression of GFP in
the tectal vessels. When we quantiﬁed GFP expression
in these vessels, this was signiﬁcantly reduced by glu-
cose exposure, which was rescued by SNP co-treatment
(Figure 7(b)). These data suggest that the negative
eﬀects of glucose on cerebrovascular development and
neurovascular coupling may be mediated, at least in
part, by alteration of BBB structure or integrity.
Discussion
In this paper, we establish a novel approach for inves-
tigating neurovascular coupling, exploiting powerful
imaging and image analysis techniques in sophisticated
compound transgenic zebraﬁsh that allow totally non-
invasive simultaneous assessment of multiple aspects of
cerebrovascular anatomy and cellular function and
physiology. We prove the utility of this model by show-
ing that exposure to elevated glucose levels as seen in
diabetes impairs both neurovascular coupling and cere-
brovascular patterning in zebraﬁsh, and that these def-
icits are reversed or prevented by the NO donor SNP.
The zebraﬁsh is well established as a model of
embryonic development, whose advantages are increas-
ingly applied to the study of physiology and disease-
related mechanisms. We describe the ﬁrst non-mamma-
lian example of neurovascular coupling, ﬁnding that
zebraﬁsh exhibit a response to neural stimulus analo-
gous to rodents and humans. This suggests neurovas-
cular coupling is evolutionarily conserved, presumably
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Figure 5. Sodium nitroprusside reverses the effect of glucose exposure on cerebrovascular patterning. (a) Gannt chart indicating
treatment groups and duration of drugs exposures for experiments in Figures 6 and 7. (b) Representative micrographs of cerebral
vessels of 9 dpf Tg(kdrl:mCherry) larvae exposed to mannitol or glucose SNP. (c) Quantification of number of tectal vascular branch
points in all groups (n¼ 23 larvae/group). (d) Quantification of total tectal vessel length in same animals as in (c). (e) Mean tectal vessel
radius for the same animals as in (c) (n¼ 23 larvae/group). (f) Histogram of radii of vessels in the left optic tectum in the same animals
as in (c). Scale bar represents 20mm. *p< 0.05, **p< 0.01, ***p< 0.005. Scale bar represents 20mm. Data in (f) are mean s.d.
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Figure 6. Sodium nitroprusside reverses the effect of glucose on neurovascular coupling. (a)–(d) Time series of neuronal activation
(F/Fo) and tectal vessel RBC speed in zebrafish (5 larvae/group) exposed to: (a) 20mM mannitol for 120 h from 4 to 9 dpf. (b) 20mM
mannitol for 120 h from 4 to 9 dpf and 0.1mM SNP for 24 h from 8 to 9 dpf. (c) 20mM glucose for 120 h from 4 to 9 dpf. (d) 20mM
glucose for 120 h from 4 to 9 dpf and 0.1mM SNP for 24 h from 8 to 9 dpf. (e) Frequency of peaks of neuronal activation during
baseline, response and recovery time periods in mannitol or glucose exposed larvae with or without co-treatment with 0.1mM SNP
(n¼ 20 larvae/group). (f) RBC speed for baseline, response and recovery for same animals in (e). (g) Beating heart rate (bpm)
quantified for baseline, response and recovery time periods for larvae exposed to 20mM mannitol, 20mM glucose with or without
SNP treatment. *p< 0.05, **p< 0.01, ***p< 0.001, ****p< 0.0001. Data are mean s.d.
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predating the phylogenetic divergence of mammals
from teleosts. Our zebraﬁsh model is less expensive
and time-consuming than rodent models and requires
no invasive surgery. It could be used to address a range
of questions that would be challenging to test in
rodents, such as rapid evaluation of the eﬀect of mul-
tiple small molecule drugs.29 The ease of genetic
manipulation of zebraﬁsh,30 the availability of thou-
sands of zebraﬁsh mutants,31,32 and the speed at
which candidate genes can be targeted by CRISPR/
Cas9 mutagenesis,33 would allow large genetic screens
to identify the molecular contributors to neurovascular
function.
Although our data clearly demonstrate that zebra-
ﬁsh exhibit neurovascular coupling, it is not known
whether the mechanisms of this are entirely conserved
between zebraﬁsh and mammals; 70% of human dis-
ease-related genes have zebraﬁsh orthologues,34 and it
Figure 7. Claudin 5a:GFP expression in tectal vessels in zebrafish larvae treatment with mannitol or glucose with or without SNP. (a)
Representative micrographs of Tg(claudin5a:GFP;kdrl:mCherry) exposed to 20mM mannitol for five days or 20mM glucose for five days
with or without SNP (one day treatment) imaged at 9 dpf. (b) Quantification of mean GFP fluorescence in the tectal vessels (n¼ 23,
19, 24 and 19 larvae for mannitol, mannitolþSNP, glucose and glucoseþSNP-treated larvae, respectively).
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is likely that the same broad mechanisms control zebra-
ﬁsh neurovascular coupling, but it remains to be deter-
mined whether all known or potential regulators of
mammalian neurovascular coupling exist in zebraﬁsh.
Diabetes is a complex disease, of which elevated
blood glucose, although an essential feature, is only
one facet. Type II diabetes is associated with both
hyperinsulinaema and insulin resistance, while type I
diabetes is associated with low insulin production, all
of which may have eﬀects separate to elevated glucose.
Exposure to glucose is therefore not a model of diabetes
per se, but the ability to examine the eﬀect of this single
(and deﬁning) feature of diabetes has utility. Other stu-
dies have applied this approach,35–37 although often
using far higher levels of glucose than seen in human
diabetics. The average blood glucose level in adult zeb-
raﬁsh is around 3.1–7.1mM (56–130mg/dL37), similar
to a non-diabetic human. We therefore examined the
eﬀect of exposure to glucose concentrations often
found in diabetic humans (20mM/360mg/dL). Adult
pdx-1 mutant zebraﬁsh which develop diabetes have
mean blood glucose levels of 219mg/dL (12mM),
while streptozotocin-induced pancreatic damage raises
blood glucose levels in adult zebraﬁsh to similar levels
to diabetic humans.38 Although no study has success-
fully measured blood glucose in zebraﬁsh larvae or
embryos, these data suggest our study examined the
eﬀect of a relevant level of glucose exposure. The nega-
tive eﬀects of glucose were not apparent after 60 h
exposure, but required 120 h to manifest and became
more marked with longer exposure, which is in keeping
with the chronic nature of diabetic complications.
Hyperglycemia is often present in type II diabetics for
years prior to and after diagnosis. Even subtle eﬀects of
hyperglycemia on cerebrovascular function might
therefore accumulate to eventually induce clinical
sequelae.
Gestational diabetes complicates 1–14% of human
pregnancies and exposes a non-diabetic human fetus to
elevated glucose which crosses the placenta from the
diabetic mother.39 It is increasingly apparent that this
exposure increases the risk of cardiovascular disease in
the oﬀspring’s later life.40,41 Our data strongly suggest
that sustained exposure to hyperglycemia during
embryogenesis compromises fetal cerebrovascular
development and function. Although not conclusive,
evidence exists to suggest that exposure to hypergly-
caemia in utero may negatively aﬀect postnatal cogni-
tion in humans.42 This underlines the importance of
understanding the eﬀect of glucose on the developing
embryonic brain, as in our study.
Diabetes is associated with dysfunctional neurovas-
cular coupling in both humans43 and rodent models.6
In addition, diabetes impairs angiogenesis and vascular
remodelling in both humans and mice,44,45 although the
eﬀect on cerebrovascular development has been less
well studied. In our model, chronic exposure to elevated
glucose levels results in cerebrovascular patterning
defects and impairs neurovascular coupling in 9 dpf
zebraﬁsh. Our ﬁndings extend those in adult zebraﬁsh
which previously demonstrated diabetes-associated
micro and macrovascular disease.46,47
Since diabetes and hyperglycemia are associated
with impaired endothelial NO generation25,48 and
both angiogenesis49 and neurovascular coupling50 are
NO dependent, we speculated that the observed defects
arise as a result of reduced bioavailability of endothelial
NO. Hence, we tested the eﬀect of an NO donor, SNP.
Administration of SNP resulted in a marked reversal of
vascular patterning and neurovascular coupling defects.
These results suggest that diabetes-associated neurovas-
cular and cerebrovascular defects may be treatable by
NO donating drugs which are already widely used clin-
ically to treat cardiovascular diseases such as hyperten-
sion and angina pectoris.13,51
The exact mechanisms underlying the eﬀects of glu-
cose, and the ability of SNP to rescue these in our
model remain to be elucidated. We found that a clau-
din5a transgene expression was reduced by glucose and
rescued by SNP co-treatment in a manner which mir-
rors the eﬀects of these treatments on cerebrovascular
patterning and neurovascular coupling. This interesting
observation might support the possibility that the
eﬀects of glucose are mediated by alteration of the
structure of the blood–brain barrier. It is also possible
that increasing NO reverses high glucose-evoked dys-
functional endothelial-dependent vasodilation52,53 and
reduced NO-mediated vasodilation.54,55 However, in
diabetic rats, deﬁcits in retinal functional hyperaemia
were reversed by inhibition of inducible NO synthase
(iNOS56). Therefore, future work should elucidate the
mechanisms underlying high glucose-evoked neurovas-
cular and cerebrovascular deﬁcits in zebraﬁsh and their
improvement by the addition of NO. Although the
safety of any drug in pregnancy is uncertain, NO
donors are one of the few classes of agents that are
not prohibited during pregnancy and can be used
where justiﬁed by the clinical beneﬁts (FDA class C).
A clinical study to examine the eﬀect of NO donors to
prevent hyperglycemia-induced impairment of fetal
cerebrovascular development is therefore not incon-
ceivable, although would require a better understand-
ing of the lifetime risk to the fetus of gestational
diabetes. Since this risk is challenging to quantify in
humans without large longitudinal cohort studies,
models such as ours contribute to understanding the
potential magnitude of any eﬀect, and may help in iden-
tifying markers (such as impaired neurovascular cou-
pling, which can be measured non-invasively by fMRI
in humans) to examine in such studies.
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Cognitive decline in neurodegenerative diseases4,57,58
is linked to neurovascular dysfunction and vascular
defects seen in diabetes.59,60 Further work is thus
needed to assess whether improvements in neurovascu-
lar coupling due to NO donor administration provide
an eﬀective means of ameliorating diabetes-associated
cognitive dysfunction.61
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